Progyny, Inc. - 8-K Filing
Progyny reported Q1 2026 revenue of $328.5 million, up 1.4% from $324.0 million in Q1 2025, with a 12.2% increase excluding a non-renewing large client. Net income rose to $24.2 million ($0.29 per diluted share) from $15.1 million ($0.17 per diluted share). The company repurchased 8.8 million shares for $116.4 million under its $200 million buyback program, which was completed by March 31, 2026. (Items: 2.02 Results of Operations and Financial Condition and Item 7, 9.01 Financial Statements and Exhibits)
Tickers: $PGNY